Atara Biotherapeutics, Inc. · NASDAQ:ATRA
Fust Matthew K received 12,000 Atara Biotherapeutics, Inc. shares as an award (Form 4)
Traded Jun 9, 2026 · Filed Jun 11, 2026
On Jun 9, 2026, Fust Matthew K (Director) received 12,000 Atara Biotherapeutics, Inc. shares as an award, leaving 30,188 shares. Filed Jun 11, 2026 (Form 4).
- Awarded
- 12,000 shares
- Holding after
- 30,188 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Award | 12,000 | 30,188 | Direct |
Source
Related
- Atara Biotherapeutics, Inc.
- Fust Matthew K
- Atara Biotherapeutics, Inc. shareholders
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Redmile Group, LLC · Jul 24, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026